The Difficult-to-Treat del 17 p Patient—A Case Report in Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) treatment strategies have evolved to include mechanism-driven drugs but now raise new questions regarding their optimum timing and sequencing. In high-risk patients, switching from pathway inhibitors to allogeneic stem cell transplantation (allo-HCT) is still a mat...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2021-12-01
|
| Edice: | Medicina |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/1648-9144/58/1/33 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|